Steroid-Refractory Chronic Graft-Versus-Host Disease: Treatment Options and Nursing Care

被引：0
|
作者：
Cazeau, Naomi [1 ]
Rodriguez, Stephany [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
[2] Univ Calif San Francisco, Dept Hematol Blood & Marrow Transplant & Cellular, San Francisco, CA USA
来源：
CLINICAL JOURNAL OF ONCOLOGY NURSING | 2023年 / 27卷 / 03期
基金：
美国国家卫生研究院;
关键词：
stem cell transplantation; graft-versus-host disease; steroid-refractory GVHD; CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; CRITERIA; TRANSPLANTATION; FAILURE;
D O I：
10.1188/23.CJON.259-265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
BACKGROUND: Chronic graft-versus-host disease (cGVHD) is a significant complication for patients who receive allogeneic hematopoietic stem cell transplantation. This disease is further complicated for patients who are refractory to steroids. This article reviews emerging therapies and supportive care for patients with steroid-refractory cGVHD.OBJECTIVES:This article provides foundational knowledge on steroid-refractory cGVHD, emerg-ing treatment options, and related supportive care.METHODS: Current research on emerging therapies for patients with steroid-refractory cGVHD is summarized along with supportive care recommendations and a review of related nursing considerations.FINDINGS: Emerging therapies for steroid -refractory cGVHD offer opportunities for improved clinical outcomes for these patients. Nursing knowledge of new therapies and supportive care for patients with steroid-refractory cGVHD supports the provision of optimal nursing care for a complex population of patients.
引用
收藏
页码：259 / 265
页数：7
相关论文
共 50 条
  • [41] FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Przepiorka, Donna
    Luo, Lola
    Subramaniam, Sriram
    Qiu, Junshan
    Gudi, Ramadevi
    Cunningham, Lea C.
    Nie, Lei
    Leong, Ruby
    Ma, Lian
    Sheth, Christopher
    Deisseroth, Albert
    Goldberg, Kirsten B.
    Blumenthal, Gideon M.
    Pazdur, Richard
    ONCOLOGIST, 2020, 25 (02): : E328 - E334
  • [42] Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
    Koshy, Anita G.
    Kim, Haesook T.
    Liegel, Jessica
    Arnason, Jon
    Ho, Vincent T.
    Antin, Joseph H.
    Joyce, Robin
    Cutler, Corey
    Gooptu, Mahasweta
    Nikiforow, Sarah
    Logan, Emma K.
    Elavalakanar, Pavania
    Narcis, Michele
    Stroopinsky, Dina
    Avigan, Zachary M.
    Boussi, Leora
    Stephenson, Susan
    El Banna, Hassan
    Bindal, Poorva
    Cheloni, Giulia
    Avigan, David E.
    Soiffer, Robert J.
    Rosenblatt, Jacalyn
    BLOOD, 2023, 141 (24) : 2932 - 2943
  • [43] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
    Meunier, Mathieu
    Bulabois, Claude Eric
    Thiebaut-Bertrand, Anne
    Itzykson, Raphael
    Carre, Martin
    Carras, Sylvain
    Garban, Frederic
    Cahn, Jean Yves
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
  • [44] How I treat steroid-refractory acute graft-versus-host disease
    Martin, Paul J.
    BLOOD, 2020, 135 (19) : 1630 - 1638
  • [45] Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease
    Rashidi, Armin
    DeFor, Todd E.
    Holtan, Shernan G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2297 - 2302
  • [46] Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis
    Yalniz, Fevzi F.
    Murad, Mohammad H.
    Lee, Stephanie J.
    Pavletic, Steven Z.
    Khera, Nandita
    Shah, Nilay D.
    Hashmi, Shahrukh K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) : 1920 - 1927
  • [47] Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease
    Mahmoudjafari, Zahra
    Bhatt, Valkal
    Galvin, John
    Xue, Zhenyi
    Zeiser, Robert
    Locatelli, Franco
    Socie, Gerard
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2025, 60 (01) : 69 - 78
  • [48] Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
    Zeiser, Robert
    Polverelli, Nicola
    Ram, Ron
    Hashmi, Shahrukh K.
    Chakraverty, Ronjon
    Middeke, Jan Moritz
    Musso, Maurizio
    Giebel, Sebastian
    Uzay, Ant
    Langmuir, Peter
    Hollaender, Norbert
    Gowda, Maanasa
    Stefanelli, Tommaso
    Lee, Stephanie J.
    Teshima, Takanori
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 228 - 238
  • [49] Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis
    Kharfan-Dabaja, Mohamed A.
    Mhaskar, Asmita R.
    Djulbegovic, Benjamin
    Cutler, Corey
    Mohty, Mohamad
    Kumar, Ambuj
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1005 - 1013
  • [50] Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
    Teshima, Takanori
    Nagafuji, Koji
    Henzan, Hideho
    Miyamura, Koichi
    Takase, Ken
    Hidaka, Michihiro
    Miyamoto, Toshihiro
    Takenaka, Katsuto
    Akashi, Koichi
    Harada, Mine
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (02) : 253 - 260
12345